2022 Q1 Form 10-Q Financial Statement

#000163159622000024 Filed on April 25, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $79.66M $65.92M
YoY Change 20.84% -5.21%
Cost Of Revenue $32.46M $27.38M
YoY Change 18.55% -29.94%
Gross Profit $47.20M $38.54M
YoY Change 22.47% 26.53%
Gross Profit Margin 59.25% 58.46%
Selling, General & Admin $8.133M $9.040M
YoY Change -10.03% 9.18%
% of Gross Profit 17.23% 23.46%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $11.79M $8.400M
YoY Change 40.35% -13.22%
Operating Profit $35.41M $30.14M
YoY Change 17.49% 45.04%
Interest Expense $32.46M $27.38M
YoY Change 18.54% -29.93%
% of Operating Profit 91.66% 90.85%
Other Income/Expense, Net $6.430M $1.156M
YoY Change 456.23% -175.02%
Pretax Income $35.41M $30.14M
YoY Change 17.49% -187.39%
Income Tax $0.00 $48.00K
% Of Pretax Income 0.0% 0.16%
Net Earnings $35.47M $30.09M
YoY Change 17.87% -187.04%
Net Earnings / Revenue 44.52% 45.65%
Basic Earnings Per Share $0.47 $0.52
Diluted Earnings Per Share $0.46 $0.52
COMMON SHARES
Basic Shares Outstanding 63.09M shares 55.62M shares
Diluted Shares Outstanding 69.40M shares 55.73M shares

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $173.2M $209.3M
YoY Change -17.26% -43.42%
Cash & Equivalents $173.2M $209.3M
Short-Term Investments
Other Short-Term Assets $700.0K $200.0K
YoY Change 250.0%
Inventory
Prepaid Expenses
Receivables $20.49M $16.50M
Other Receivables $0.00 $0.00
Total Short-Term Assets $194.4M $226.0M
YoY Change -14.0% -41.63%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $36.60M $33.60M
YoY Change 8.91% -2.33%
Other Assets $6.300M $2.300M
YoY Change 173.91% -25.81%
Total Long-Term Assets $6.955B $5.047B
YoY Change 37.82% -0.43%
TOTAL ASSETS
Total Short-Term Assets $194.4M $226.0M
Total Long-Term Assets $6.955B $5.047B
Total Assets $7.150B $5.273B
YoY Change 35.6% -3.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.126M $700.0K
YoY Change 346.57% -87.04%
Accrued Expenses $12.03M $11.10M
YoY Change 8.36% 0.91%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $53.23M $41.00M
YoY Change 29.84% -10.09%
LONG-TERM LIABILITIES
Long-Term Debt $5.445B $4.179B
YoY Change 30.31% -4.55%
Other Long-Term Liabilities $1.800M
YoY Change
Total Long-Term Liabilities $5.447B $4.179B
YoY Change 30.35% -4.55%
TOTAL LIABILITIES
Total Short-Term Liabilities $53.23M $41.00M
Total Long-Term Liabilities $5.447B $4.179B
Total Liabilities $5.500B $4.220B
YoY Change 30.35% -4.61%
SHAREHOLDERS EQUITY
Retained Earnings -$37.62M -$60.43M
YoY Change -37.75% 603.16%
Common Stock $679.0K $556.0K
YoY Change 22.12% -3.3%
Preferred Stock
YoY Change
Treasury Stock (at cost) $61.00M $61.00M
YoY Change 0.0% 10.5%
Treasury Stock Shares
Shareholders Equity $1.650B $1.051B
YoY Change
Total Liabilities & Shareholders Equity $7.150B $5.273B
YoY Change 35.6% -3.35%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income $35.47M $30.09M
YoY Change 17.87% -187.04%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $33.13M $30.27M
YoY Change 9.46% 10.56%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$530.5M -$201.2M
YoY Change 163.66% 30.14%
Cash From Investing Activities -$530.5M -$201.2M
YoY Change 163.62% 30.17%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $135.3M $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $398.5M $269.5M
YoY Change 47.86% -37.25%
NET CHANGE
Cash From Operating Activities $33.13M $30.27M
Cash From Investing Activities -$530.5M -$201.2M
Cash From Financing Activities $398.5M $269.5M
Net Change In Cash -$98.88M $98.52M
YoY Change -200.37% -67.41%
FREE CASH FLOW
Cash From Operating Activities $33.13M $30.27M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001631596
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
001-38082
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
KKR Real Estate Finance Trust Inc.
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-2009094
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
30 Hudson Yards,
CY2022Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 7500
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
New York,
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10001
CY2022Q1 dei City Area Code
CityAreaCode
212
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
750-8300
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
67933704 shares
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
173178000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
271487000 USD
CY2022Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
6772884000 USD
CY2021Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
6316733000 USD
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
20676000 USD
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
22244000 USD
CY2022Q1 us-gaap Notes Receivable Net
NotesReceivableNet
6752208000 USD
CY2021Q4 us-gaap Notes Receivable Net
NotesReceivableNet
6294489000 USD
CY2022Q1 us-gaap Real Estate Acquired Through Foreclosure
RealEstateAcquiredThroughForeclosure
78569000 USD
CY2021Q4 us-gaap Real Estate Acquired Through Foreclosure
RealEstateAcquiredThroughForeclosure
78569000 USD
CY2022Q1 us-gaap Equity Method Investments Fair Value Disclosure
EquityMethodInvestmentsFairValueDisclosure
36595000 USD
CY2021Q4 us-gaap Equity Method Investments Fair Value Disclosure
EquityMethodInvestmentsFairValueDisclosure
35537000 USD
CY2022Q1 us-gaap Interest Receivable
InterestReceivable
19091000 USD
CY2021Q4 us-gaap Interest Receivable
InterestReceivable
15241000 USD
CY2022Q1 us-gaap Other Assets
OtherAssets
90122000 USD
CY2021Q4 us-gaap Other Assets
OtherAssets
7916000 USD
CY2022Q1 us-gaap Assets
Assets
7149763000 USD
CY2021Q4 us-gaap Assets
Assets
6703239000 USD
CY2022Q1 us-gaap Line Of Credit
LineOfCredit
3035230000 USD
CY2021Q4 us-gaap Line Of Credit
LineOfCredit
3726593000 USD
CY2022Q1 kref Collateralized Loan Obligations Net
CollateralizedLoanObligationsNet
1929616000 USD
CY2021Q4 kref Collateralized Loan Obligations Net
CollateralizedLoanObligationsNet
1087976000 USD
CY2022Q1 us-gaap Secured Debt
SecuredDebt
337971000 USD
CY2021Q4 us-gaap Secured Debt
SecuredDebt
338549000 USD
CY2022Q1 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
142193000 USD
CY2021Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
141851000 USD
CY2022Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
29411000 USD
CY2021Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
26589000 USD
CY2022Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
9528000 USD
CY2021Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
6627000 USD
CY2022Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
7426000 USD
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
7521000 USD
CY2022Q1 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
8668000 USD
CY2021Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
5952000 USD
CY2022Q1 us-gaap Liabilities
Liabilities
5500043000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
5341658000 USD
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
71834030 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
65271058 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
67933704 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
61370732 shares
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
679000 USD
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
613000 USD
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1747340000 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1459959000 USD
CY2022Q1 us-gaap Escrow Deposit
EscrowDeposit
80900000 USD
CY2022Q1 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
1800000 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-37616000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-38208000 USD
CY2021Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
3900326 shares
CY2022Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
3900326 shares
CY2022Q1 us-gaap Treasury Stock Value
TreasuryStockValue
60999000 USD
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
60999000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
1649535000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1361434000 USD
CY2022Q1 us-gaap Minority Interest
MinorityInterest
185000 USD
CY2021Q4 us-gaap Minority Interest
MinorityInterest
147000 USD
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1649720000 USD
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1361581000 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7149763000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6703239000 USD
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1700000 USD
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
2300000 USD
CY2021Q4 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
1500000 USD
CY2022Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
73230000 USD
CY2021Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
64766000 USD
CY2022Q1 us-gaap Interest Expense
InterestExpense
32459000 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
27383000 USD
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
40771000 USD
CY2021Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
37383000 USD
CY2022Q1 us-gaap Profit Loss From Real Estate Operations
ProfitLossFromRealEstateOperations
2629000 USD
CY2021Q1 us-gaap Profit Loss From Real Estate Operations
ProfitLossFromRealEstateOperations
0 USD
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1886000 USD
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1090000 USD
CY2022Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
1915000 USD
CY2021Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
66000 USD
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6430000 USD
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1156000 USD
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4446000 USD
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3505000 USD
CY2022Q1 kref Credit Loss Expense Reversal
CreditLossExpenseReversal
-1218000 USD
CY2021Q1 kref Credit Loss Expense Reversal
CreditLossExpenseReversal
-1588000 USD
CY2022Q1 kref Management Fees To Affiliate
ManagementFeesToAffiliate
6007000 USD
CY2021Q1 kref Management Fees To Affiliate
ManagementFeesToAffiliate
4290000 USD
CY2022Q1 us-gaap Noninterest Expense Related To Performance Fees
NoninterestExpenseRelatedToPerformanceFees
0 USD
CY2021Q1 us-gaap Noninterest Expense Related To Performance Fees
NoninterestExpenseRelatedToPerformanceFees
2192000 USD
CY2022Q1 kref Property Operating Expense
PropertyOperatingExpense
2554000 USD
CY2021Q1 kref Property Operating Expense
PropertyOperatingExpense
0 USD
CY2022Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
11789000 USD
CY2021Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
8399000 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
35412000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
30140000 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
48000 USD
CY2022Q1 us-gaap Profit Loss
ProfitLoss
35412000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
30092000 USD
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-56000 USD
CY2021Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
35468000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
30092000 USD
CY2022Q1 kref Preferred Stock Redemption Adjustment And Dividends Income Statement Impact
PreferredStockRedemptionAdjustmentAndDividendsIncomeStatementImpact
5326000 USD
CY2021Q1 kref Preferred Stock Redemption Adjustment And Dividends Income Statement Impact
PreferredStockRedemptionAdjustmentAndDividendsIncomeStatementImpact
908000 USD
CY2022Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
346000 USD
CY2021Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 USD
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
29796000 USD
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
29184000 USD
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.47
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.52
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.46
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.52
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
63086452 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55619428 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69402626 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
55731061 shares
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.43
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.43
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1361581000 USD
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
1055000 USD
CY2022Q1 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
94000 USD
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.43
CY2022Q1 us-gaap Dividends Common Stock
DividendsCommonStock
29211000 USD
CY2022Q1 kref Participating Security Dividends Per Share Declared
ParticipatingSecurityDividendsPerShareDeclared
0.43
CY2022Q1 kref Dividends Participating Securities
DividendsParticipatingSecurities
339000 USD
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2126000 USD
CY2022Q1 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
35412000 USD
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1649720000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1043554000 USD
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.43
CY2021Q1 us-gaap Dividends Common Stock
DividendsCommonStock
23916000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1994000 USD
CY2021Q1 us-gaap Increase In Carrying Amount Of Redeemable Preferred Stock
IncreaseInCarryingAmountOfRedeemablePreferredStock
710000 USD
CY2021Q1 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
29894000 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1050816000 USD
CY2022Q1 us-gaap Profit Loss
ProfitLoss
35412000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
30092000 USD
CY2022Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
4844000 USD
CY2021Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3660000 USD
CY2022Q1 kref Accretion Of Deferred Loan Costs And Discounts
AccretionOfDeferredLoanCostsAndDiscounts
6083000 USD
CY2021Q1 kref Accretion Of Deferred Loan Costs And Discounts
AccretionOfDeferredLoanCostsAndDiscounts
4460000 USD
CY2022Q1 kref Payments For Interest Paid In Kind
PaymentsForInterestPaidInKind
464000 USD
CY2021Q1 kref Payments For Interest Paid In Kind
PaymentsForInterestPaidInKind
845000 USD
CY2022Q1 kref Increase Decreasein Equity Method Investments
IncreaseDecreaseinEquityMethodInvestments
1058000 USD
CY2021Q1 kref Increase Decreasein Equity Method Investments
IncreaseDecreaseinEquityMethodInvestments
288000 USD
CY2022Q1 kref Credit Loss Expense Reversal
CreditLossExpenseReversal
-1218000 USD
CY2021Q1 kref Credit Loss Expense Reversal
CreditLossExpenseReversal
-1588000 USD
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2126000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1994000 USD
CY2022Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
3850000 USD
CY2021Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
1101000 USD
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-985000 USD
CY2021Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-82000 USD
CY2022Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
2901000 USD
CY2021Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
2487000 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-532000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
246000 USD
CY2022Q1 us-gaap Increase Decrease In Due To Affiliates
IncreaseDecreaseInDueToAffiliates
67000 USD
CY2021Q1 us-gaap Increase Decrease In Due To Affiliates
IncreaseDecreaseInDueToAffiliates
-11000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
33130000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
30268000 USD
CY2022Q1 us-gaap Proceeds From Principal Repayments On Loans And Leases Held For Investment
ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
282282000 USD
CY2021Q1 us-gaap Proceeds From Principal Repayments On Loans And Leases Held For Investment
ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
370566000 USD
CY2022Q1 us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
812756000 USD
CY2021Q1 us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
571796000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-530474000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-201230000 USD
CY2022Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
479329000 USD
CY2021Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
718112000 USD
CY2022Q1 kref Proceeds From Issuance Of Collateralized Loan Obligation
ProceedsFromIssuanceOfCollateralizedLoanObligation
847500000 USD
CY2021Q1 kref Proceeds From Issuance Of Collateralized Loan Obligation
ProceedsFromIssuanceOfCollateralizedLoanObligation
0 USD
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
135271000 USD
CY2021Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2022Q1 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
151167000 USD
CY2021Q1 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
0 USD
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
26389000 USD
CY2021Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
23916000 USD
CY2022Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
5326000 USD
CY2021Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
366000 USD
CY2022Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
1172268000 USD
CY2021Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
422096000 USD
CY2022Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
9787000 USD
CY2021Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
433000 USD
CY2022Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1036000 USD
CY2021Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
104000 USD
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 USD
CY2021Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1720000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
398461000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
269477000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-98883000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
98515000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
273770000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
110832000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
174887000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
209347000 USD
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
173178000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
209347000 USD
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1709000 USD
CY2021Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
0 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
174887000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
209347000 USD
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
24715000 USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
20561000 USD
CY2022Q1 kref Escrow Deposits Related To Financing Receivable
EscrowDepositsRelatedToFinancingReceivable
80870000 USD
CY2021Q1 kref Escrow Deposits Related To Financing Receivable
EscrowDepositsRelatedToFinancingReceivable
0 USD
CY2022Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2021Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2022Q1 kref Loan Principal Payments Held By Servicer
LoanPrincipalPaymentsHeldByServicer
0 USD
CY2021Q1 kref Loan Principal Payments Held By Servicer
LoanPrincipalPaymentsHeldByServicer
40000000 USD
CY2022Q1 us-gaap Dividends
Dividends
29211000 USD
CY2021Q1 us-gaap Dividends
Dividends
24119000 USD
CY2022Q1 kref Deferred Financing Costs Incurred But Not Yet Paid
DeferredFinancingCostsIncurredButNotYetPaid
3314000 USD
CY2021Q1 kref Deferred Financing Costs Incurred But Not Yet Paid
DeferredFinancingCostsIncurredButNotYetPaid
0 USD
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— The preparation of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">condensed consolidated</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">condensed consolidated</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> financial statements and the reported amounts of revenue and expenses during the reporting period. Management makes subjective estimates to project cash flows KREF expects to receive on its investments in loans and securities as well as the related market discount rates, which significantly impacts the interest income, impairments, allowance for loan loss and fair values recorded or disclosed. The effects of COVID-19 may negatively and materially impact significant estimates and assumptions used by the Company including, but not limited to estimates of expected credit losses, valuation of our equity method investments and the fair value estimates of the Company’s assets and liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actual results could materially differ from those estimates.</span>
CY2022Q1 kref Debt Instrument Covenant Liquidity Required Cashand Cash Equivalents
DebtInstrumentCovenantLiquidityRequiredCashandCashEquivalents
44300000 USD
CY2021Q4 kref Debt Instrument Covenant Liquidity Required Cashand Cash Equivalents
DebtInstrumentCovenantLiquidityRequiredCashandCashEquivalents
65600000 USD
CY2022Q1 us-gaap Restricted Cash
RestrictedCash
1700000 USD
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
2300000 USD
CY2022Q1 us-gaap Escrow Deposit
EscrowDeposit
80900000 USD
CY2022Q1 us-gaap Restricted Cash
RestrictedCash
1700000 USD
CY2022Q1 kref Real Estate Owned Accounts Receivable
RealEstateOwnedAccountsReceivable
1400000 USD
CY2022Q1 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
700000 USD
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
2300000 USD
CY2021Q4 kref Interest Held At Servicer
InterestHeldAtServicer
1400000 USD
CY2021Q4 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
1400000 USD
CY2022Q1 kref Real Estate Owned Liability
RealEstateOwnedLiability
2900000 USD
CY2022Q1 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
2500000 USD
CY2022Q1 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
1800000 USD
CY2021Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
3900000 USD
CY2021Q4 kref Real Estate Owned Liability
RealEstateOwnedLiability
3300000 USD
CY2021Q4 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
1500000 USD
CY2021Q4 us-gaap Deferred Income
DeferredIncome
600000 USD
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.43
CY2022Q1 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
5500000 USD
CY2022Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
6316174 shares
CY2022Q1 kref Net Accelerated Fees
NetAcceleratedFees
800000 USD
CY2021Q1 kref Net Accelerated Fees
NetAcceleratedFees
1000000 USD
CY2022Q1 kref Weighted Average Loan Risk Rating
WeightedAverageLoanRiskRating
2.9
CY2021Q4 kref Weighted Average Loan Risk Rating
WeightedAverageLoanRiskRating
2.9
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
22244000 USD
CY2021Q4 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
1495000 USD
CY2021Q4 kref Allowance For Credit Loss
AllowanceForCreditLoss
23739000 USD
CY2022Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-1568000 USD
CY2022Q1 us-gaap Off Balance Sheet Credit Loss Liability Credit Loss Expense Reversal
OffBalanceSheetCreditLossLiabilityCreditLossExpenseReversal
350000 USD
CY2022Q1 kref Credit Loss Expense Reversal
CreditLossExpenseReversal
-1218000 USD
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
0 USD
CY2022Q1 kref Off Balance Sheet Credit Loss Liability Writeoff
OffBalanceSheetCreditLossLiabilityWriteoff
0 USD
CY2022Q1 kref Allowance For Credit Loss Writeoff
AllowanceForCreditLossWriteoff
0 USD
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
0 USD
CY2022Q1 kref Off Balance Sheet Credit Loss Liability Recovery
OffBalanceSheetCreditLossLiabilityRecovery
0 USD
CY2022Q1 kref Allowance For Credit Loss Recovery
AllowanceForCreditLossRecovery
0 USD
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
20676000 USD
CY2022Q1 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
1845000 USD
CY2022Q1 kref Allowance For Credit Loss
AllowanceForCreditLoss
22521000 USD
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
59801000 USD
CY2020Q4 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
902000 USD
CY2020Q4 kref Allowance For Credit Loss
AllowanceForCreditLoss
60703000 USD
CY2021Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-1328000 USD
CY2021Q1 us-gaap Off Balance Sheet Credit Loss Liability Credit Loss Expense Reversal
OffBalanceSheetCreditLossLiabilityCreditLossExpenseReversal
-260000 USD
CY2021Q1 kref Credit Loss Expense Reversal
CreditLossExpenseReversal
-1588000 USD
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
0 USD
CY2021Q1 kref Off Balance Sheet Credit Loss Liability Writeoff
OffBalanceSheetCreditLossLiabilityWriteoff
0 USD
CY2021Q1 kref Allowance For Credit Loss Writeoff
AllowanceForCreditLossWriteoff
0 USD
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
0 USD
CY2021Q1 kref Off Balance Sheet Credit Loss Liability Recovery
OffBalanceSheetCreditLossLiabilityRecovery
0 USD
CY2021Q1 kref Allowance For Credit Loss Recovery
AllowanceForCreditLossRecovery
0 USD
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
58473000 USD
CY2021Q1 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
642000 USD
CY2021Q1 kref Allowance For Credit Loss
AllowanceForCreditLoss
59115000 USD
CY2022Q1 kref Credit Loss Expense Reversal
CreditLossExpenseReversal
-1200000 USD
CY2021Q1 kref Credit Loss Expense Reversal
CreditLossExpenseReversal
-1600000 USD
CY2021Q4 kref Real Estate Owned Other Assets Assumed
RealEstateOwnedOtherAssetsAssumed
2000000 USD
CY2022Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
2287000 USD
CY2022Q1 kref Other Real Estate Operations Income
OtherRealEstateOperationsIncome
342000 USD
CY2022Q1 kref Property Operating Expense
PropertyOperatingExpense
2554000 USD
CY2022Q1 us-gaap Other Revenue Expense From Real Estate Operations
OtherRevenueExpenseFromRealEstateOperations
403000 USD
CY2022Q1 kref Income Loss From Real Estate Owned Operations
IncomeLossFromRealEstateOwnedOperations
478000 USD
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
17000 USD
CY2022Q1 us-gaap Amortization Of Below Market Lease
AmortizationOfBelowMarketLease
91000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
50000 USD
CY2022Q1 us-gaap Below Market Lease Amortization Income Remainder Of Fiscal Year
BelowMarketLeaseAmortizationIncomeRemainderOfFiscalYear
274000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
67000 USD
CY2022Q1 us-gaap Below Market Lease Amortization Income Next Twelve Months
BelowMarketLeaseAmortizationIncomeNextTwelveMonths
365000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
67000 USD
CY2022Q1 us-gaap Below Market Lease Amortization Income Year Two
BelowMarketLeaseAmortizationIncomeYearTwo
365000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
67000 USD
CY2022Q1 us-gaap Below Market Lease Amortization Income Year Three
BelowMarketLeaseAmortizationIncomeYearThree
365000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
67000 USD
CY2022Q1 us-gaap Below Market Lease Amortization Income Year Four
BelowMarketLeaseAmortizationIncomeYearFour
365000 USD
CY2022Q1 us-gaap Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year
LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear
3897000 USD
CY2022Q1 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
4390000 USD
CY2022Q1 us-gaap Lessor Operating Lease Payments To Be Received Two Years
LessorOperatingLeasePaymentsToBeReceivedTwoYears
3579000 USD
CY2022Q1 us-gaap Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
2839000 USD
CY2022Q1 us-gaap Lessor Operating Lease Payments To Be Received Four Years
LessorOperatingLeasePaymentsToBeReceivedFourYears
2042000 USD
CY2022Q1 kref Lessor Operating Lease Payment To Be Received After Year Four
LessorOperatingLeasePaymentToBeReceivedAfterYearFour
45000 USD
CY2022Q1 kref Debt Instrument Average Haircut Weightedby Outstanding Face Amountof Collateral
DebtInstrumentAverageHaircutWeightedbyOutstandingFaceAmountofCollateral
0.290
CY2021Q4 kref Debt Instrument Average Haircut Weightedby Outstanding Face Amountof Collateral
DebtInstrumentAverageHaircutWeightedbyOutstandingFaceAmountofCollateral
0.303
CY2022Q1 kref Debt Instrument Average Haircut Weightedby Outstanding Face Amountof Collateral Percentageif Maximum Amountis Borrowed
DebtInstrumentAverageHaircutWeightedbyOutstandingFaceAmountofCollateralPercentageifMaximumAmountisBorrowed
0.254
CY2021Q4 kref Debt Instrument Average Haircut Weightedby Outstanding Face Amountof Collateral Percentageif Maximum Amountis Borrowed
DebtInstrumentAverageHaircutWeightedbyOutstandingFaceAmountofCollateralPercentageifMaximumAmountisBorrowed
0.259
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
590719000 USD
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
1132302000 USD
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
524675000 USD
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
442564000 USD
CY2022Q1 kref Long Term Debt Maturity After Year Four
LongTermDebtMaturityAfterYearFour
355569000 USD
CY2022Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
3045829000 USD
CY2022Q1 kref Debt Instrument Covenant Interest Incometo Interest Expense Ratio
DebtInstrumentCovenantInterestIncometoInterestExpenseRatio
1.5
CY2022Q1 kref Debt Instrument Covenant Consolidated Tangible Net Worth Minimum Percentageof Aggregate Cash Proceeds Madeand Capital Contributions Received
DebtInstrumentCovenantConsolidatedTangibleNetWorthMinimumPercentageofAggregateCashProceedsMadeandCapitalContributionsReceived
0.750
CY2022Q1 kref Debt Instrument Covenant Consolidated Tangible Net Worth Amountof Aggregate Cash Proceeds Madeand Capital Contributions Received
DebtInstrumentCovenantConsolidatedTangibleNetWorthAmountofAggregateCashProceedsMadeandCapitalContributionsReceived
1309400000 USD
CY2022Q1 kref Debt Instrument Covenant Cash Liquidity Amount
DebtInstrumentCovenantCashLiquidityAmount
10000000 USD
CY2022Q1 kref Debt Instrument Covenant Cash Liquidity Percentof Recourse Indebtedness
DebtInstrumentCovenantCashLiquidityPercentofRecourseIndebtedness
0.050
CY2022Q1 kref Debt Instrument Covenant Total Indebtedness Percentof Total Assets
DebtInstrumentCovenantTotalIndebtednessPercentofTotalAssets
0.833
CY2022Q1 kref Collateral Assets Under Collateralized Loan Obligations As A Percentage Of Commercial Mortgage Loans
CollateralAssetsUnderCollateralizedLoanObligationsAsAPercentageOfCommercialMortgageLoans
0.337
CY2021Q4 kref Collateral Assets Under Collateralized Loan Obligations As A Percentage Of Commercial Mortgage Loans
CollateralAssetsUnderCollateralizedLoanObligationsAsAPercentageOfCommercialMortgageLoans
0.196
CY2021Q4 kref Percentage Of Collateralized Loan Obligations Under Floating Rate Loans
PercentageOfCollateralizedLoanObligationsUnderFloatingRateLoans
1
CY2022Q1 kref Percentage Of Collateralized Loan Obligations Under Floating Rate Loans
PercentageOfCollateralizedLoanObligationsUnderFloatingRateLoans
1
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
55731061 shares
CY2014Q4 kref Common Stockand Preferred Stock Shares Authorized
CommonStockandPreferredStockSharesAuthorized
350000000 shares
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
67933704 shares
CY2022Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
3900326 shares
CY2022Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0 shares
CY2021Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0 shares
CY2022Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
100000000 USD
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.43
CY2022Q1 us-gaap Dividends Common Stock
DividendsCommonStock
29211000 USD
CY2022Q1 us-gaap Dividends Common Stock
DividendsCommonStock
29211000 USD
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.43
CY2021Q1 us-gaap Dividends Common Stock
DividendsCommonStock
23916000 USD
CY2021Q1 us-gaap Dividends Common Stock
DividendsCommonStock
23916000 USD
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y1M6D
CY2022Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
6316174 shares
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
35468000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
30092000 USD
CY2022Q1 kref Preferred Stock Redemption Adjustment And Dividends Income Statement Impact
PreferredStockRedemptionAdjustmentAndDividendsIncomeStatementImpact
5326000 USD
CY2021Q1 kref Preferred Stock Redemption Adjustment And Dividends Income Statement Impact
PreferredStockRedemptionAdjustmentAndDividendsIncomeStatementImpact
908000 USD
CY2022Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
346000 USD
CY2021Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 USD
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
29796000 USD
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
29184000 USD
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
29796000 USD
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
29184000 USD
CY2022Q1 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
2201000 USD
CY2021Q1 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
0 USD
CY2022Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
25000 USD
CY2021Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
0 USD
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
31972000 USD
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
29184000 USD
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
63086452 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55619428 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
6316174 shares
CY2021Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2021Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
111633 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69402626 shares
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.47
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.52
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.46
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.52
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
181560 shares
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
0 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
0 shares
CY2022Q1 us-gaap Due To Affiliate Current And Noncurrent
DueToAffiliateCurrentAndNoncurrent
8668000 USD
CY2021Q4 us-gaap Due To Affiliate Current And Noncurrent
DueToAffiliateCurrentAndNoncurrent
5952000 USD
CY2022Q1 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
6733000 USD
CY2021Q1 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
6834000 USD
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
20700000 USD
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
22200000 USD
CY2021Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 USD
CY2022Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 USD
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2022Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD

Files In Submission

Name View Source Status
0001631596-22-000024-index-headers.html Edgar Link pending
0001631596-22-000024-index.html Edgar Link pending
0001631596-22-000024.txt Edgar Link pending
0001631596-22-000024-xbrl.zip Edgar Link pending
a202203-exhibit101.htm Edgar Link pending
a202203-exhibit102.htm Edgar Link pending
a202203-exhibit103.htm Edgar Link pending
a202203-exhibit104.htm Edgar Link pending
a202203-exhibit105.htm Edgar Link pending
a202203-exhibit106.htm Edgar Link pending
a202203-exhibit107.htm Edgar Link pending
a202203-exhibit108.htm Edgar Link pending
a202203-exhibit311.htm Edgar Link pending
a202203-exhibit312.htm Edgar Link pending
a202203-exhibit321.htm Edgar Link pending
a202203-exhibit322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
kref-20220331.htm Edgar Link pending
kref-20220331.xsd Edgar Link pending
kref-20220331_cal.xml Edgar Link unprocessable
kref-20220331_def.xml Edgar Link unprocessable
kref-20220331_g1.jpg Edgar Link pending
kref-20220331_g2.jpg Edgar Link pending
kref-20220331_htm.xml Edgar Link completed
kref-20220331_lab.xml Edgar Link unprocessable
kref-20220331_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending